Dear Editor,

Since the initial description of frontal fibrosing alopecia (FFA), a number of features have been incorporated to its clinical picture. Color changes such as cutaneous hypopigmentation of the alopecic band and hyperpigmentation secondary to lichen planus pigmentosus (LPPigm) are examples that the disease transcends the hair follicle [1, 2]. In this manuscript, we describe 22 patients with FFA presenting with marked hypopigmentation of the eyebrows.

Twenty patients were women (18 postmenopausal and 2 premenopausal) and 2 men (age range 34–79 years, median age 59). All patients had skin type IV or higher and presented with bilateral hypopigmentation of the eyebrow area (Fig. 1a), which could be better appreciated on examination with a Wood’s lamp (Fig. 1b). Partial or complete loss of the eyebrows was seen in all cases. Hypopigmentation along the hairline was also noted in 18 (82%) patients (Fig. 2a). LPPigm was present in twenty cases with the diffuse pattern being the most frequent (19) followed by the reticulated pattern (1). Facial papules were observed in 13 (59%) cases.

Fig. 1.

Hypopigmentation of the eyebrows in FFA. a Clinical picture of a female patient with FFA showing bilateral hypopigmentation of the eyebrow area. b Same patient under Wood’s light examination (365-nm ultraviolet light). FFA, frontal fibrosing alopecia.

Fig. 1.

Hypopigmentation of the eyebrows in FFA. a Clinical picture of a female patient with FFA showing bilateral hypopigmentation of the eyebrow area. b Same patient under Wood’s light examination (365-nm ultraviolet light). FFA, frontal fibrosing alopecia.

Close modal
Fig. 2.

FFA. a Patient with FFA and lichen planus pigmentosus presenting with hypopigmentation along the affected hairline and eyebrows. b Dermoscopic image of the eyebrow showing a clear demarcation between the hypopigmented eyebrow and the hyperpigmented adjacent skin. FFA, frontal fibrosing alopecia.

Fig. 2.

FFA. a Patient with FFA and lichen planus pigmentosus presenting with hypopigmentation along the affected hairline and eyebrows. b Dermoscopic image of the eyebrow showing a clear demarcation between the hypopigmented eyebrow and the hyperpigmented adjacent skin. FFA, frontal fibrosing alopecia.

Close modal

Hypopigmentation of the hairline has been previously described in FFA patients. Lin et al. [1] reported that FFA epidermal melanocyte counts were found to be lower than the counts seen in biopsy specimens from patients with lichen planopilaris and controls. We speculate that same mechanism could be responsible for the hypopigmentation of the eyebrow area observed clinically. An interesting observation is the sparing of this particular region in patients with LPPigm. This same phenomenon was also observed in the hairline (Fig. 2a, b). LPPigm is characterized by interface dermatitis with pigment incontinence and melanophages in the dermis which results in clinical hyperpigmentation [3]. It could be that for some unknown reason these areas are not affected by LPPigm or, alternatively, the local reduction of melanocyte counts would lead to decreased pigment incontinence in these areas. Histopathological analysis will help to clarify this point. Finally, hypopigmentation of the eyebrows is possibly better observed in patients with dark skin types, such as the ones reported herein, due to the contrast in color.

In conclusion, we describe a series of patients presenting hypopigmentation of the eyebrow area. This new observation might be in line with Lin et al. [1] findings, suggesting a pathophysiologic connection between hair follicles in FFA and the loss of epidermal melanocytes. Sparing of the hypopigmented alopecic band and eyebrow region by LPPigm is an interesting feature that needs to be better clarified and further highlights the complexity of this disease.

Written consent for publication including images was obtained from the patients and research was conducted ethically in accordance with the World Medical Association Declaration of Helsinki.

The authors have no conflicts of interest to declare.

There were no funding sources for this work.

All authors met the criteria of the International Medical Journal Editors Committee (ICMJE) for authorship of this manuscript and approved the final manuscript. They take responsibility for the integrity of the work as a whole.

1.
Lin
J
,
Valdebran
M
,
Bergfeld
W
,
Conic
RZ
,
Piliang
M
,
Atanaskova Mesinkovska
N
.
Hypopigmentation in frontal fibrosing alopecia
.
J Am Acad Dermatol
.
2017
;
76
(
6
):
1184
6
. .
2.
Pirmez
R
,
Duque-Estrada
B
,
Donati
A
,
Campos-do-Carmo
G
,
Valente
NS
,
Romiti
R
,
et al.
Clinical and dermoscopic features of lichen planus pigmentosus in 37 patients with frontal fibrosing alopecia
.
Br J Dermatol
.
2016
;
175
(
6
):
1387
90
. .
3.
Saceda-Corralo
D
,
Desai
K
,
Pindado-Ortega
C
,
Moreno-Arrones
OM
,
Vañó-Galván
S
,
Miteva
M
.
Histological evidence for epidermal and dermal atrophy of the alopecic band in treatment-naïve patients with Frontal Fibrosing Alopecia
.
J Eur Acad Dermatol Venereol
.
2020 Jun 28
.
Online ahead of print
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.